Teyi Pharmaceutical Group Co.,Ltd

SZSE:002728 Stok Raporu

Piyasa değeri: CN¥4.6b

Teyi Pharmaceutical GroupLtd Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 2/6

Teyi Pharmaceutical GroupLtd has been growing earnings at an average annual rate of 9.9%, while the Pharmaceuticals industry saw earnings growing at 9% annually. Revenues have been growing at an average rate of 4.4% per year. Teyi Pharmaceutical GroupLtd's return on equity is 4.1%, and it has net margins of 9.1%.

Anahtar bilgiler

9.9%

Kazanç büyüme oranı

5.7%

EPS büyüme oranı

Pharmaceuticals Sektör Büyümesi10.9%
Gelir büyüme oranı4.4%
Özkaynak getirisi4.1%
Net Marj9.1%
Son Kazanç Güncellemesi30 Sep 2024

Yakın geçmiş performans güncellemeleri

Why Teyi Pharmaceutical GroupLtd's (SZSE:002728) Shaky Earnings Are Just The Beginning Of Its Problems

Apr 26
Why Teyi Pharmaceutical GroupLtd's (SZSE:002728) Shaky Earnings Are Just The Beginning Of Its Problems

Recent updates

We Think Teyi Pharmaceutical GroupLtd (SZSE:002728) Can Stay On Top Of Its Debt

Jun 06
We Think Teyi Pharmaceutical GroupLtd (SZSE:002728) Can Stay On Top Of Its Debt

Why Teyi Pharmaceutical GroupLtd's (SZSE:002728) Shaky Earnings Are Just The Beginning Of Its Problems

Apr 26
Why Teyi Pharmaceutical GroupLtd's (SZSE:002728) Shaky Earnings Are Just The Beginning Of Its Problems

Teyi Pharmaceutical Group Co.,Ltd's (SZSE:002728) Shares Bounce 29% But Its Business Still Trails The Market

Mar 06
Teyi Pharmaceutical Group Co.,Ltd's (SZSE:002728) Shares Bounce 29% But Its Business Still Trails The Market

Here's Why We Think Teyi Pharmaceutical GroupLtd (SZSE:002728) Is Well Worth Watching

Feb 27
Here's Why We Think Teyi Pharmaceutical GroupLtd (SZSE:002728) Is Well Worth Watching

Gelir ve Gider Dağılımı

Teyi Pharmaceutical GroupLtd nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.

Kazanç ve Gelir Geçmişi

SZSE:002728 Gelir, gider ve kazançlar (CNY Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Sep 247787121744
30 Jun 2484310423445
31 Mar 2492815724444
31 Dec 231,06725324143
30 Sep 231,04926922543
30 Jun 231,04026921340
31 Mar 2399623819640
31 Dec 2288717817738
30 Sep 2281612217539
30 Jun 2278511316938
31 Mar 2275813116138
01 Jan 2275812717838
30 Sep 2172511815937
30 Jun 216919215838
31 Mar 216526315937
31 Dec 206334415336
30 Sep 206686620038
30 Jun 2074310822339
31 Mar 2085215524642
31 Dec 1992117226744
30 Sep 1993916829242
30 Jun 1994917127449
31 Mar 1992617126448
31 Dec 1888515625847
30 Sep 1882814620856
30 Jun 1877712817766
31 Mar 1873911216156
31 Dec 1768710614946
30 Sep 1768911016027
30 Jun 176801051900
31 Mar 17650941930
31 Dec 16656951870
30 Sep 16648851840
30 Jun 16631841760
31 Mar 16584801610
31 Dec 15517811390
30 Sep 1541978940
30 Jun 1535674770
31 Mar 1535578680
31 Dec 1434580660
30 Sep 1434782620
30 Jun 1434585830
31 Mar 1433782690
31 Dec 1334381560

Kaliteli Kazançlar: 002728 has high quality earnings.

Büyüyen Kar Marjı: 002728's current net profit margins (9.1%) are lower than last year (25.6%).

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: 002728's earnings have grown by 9.9% per year over the past 5 years.

Büyüme Hızlandırma: 002728's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Kazançlar vs. Sektör: 002728 had negative earnings growth (-73.7%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (-1.2%).

Özkaynak Getirisi

Yüksek ROE: 002728's Return on Equity (4.1%) is considered low.

Varlık Getirisi

Kullanılan Sermaye Getirisi

Geçmişte güçlü performans gösteren şirketleri keşfedin

7D

1Y

7D

1Y

7D

1Y